FR2149952A5 - - Google Patents

Info

Publication number
FR2149952A5
FR2149952A5 FR7228435A FR7228435A FR2149952A5 FR 2149952 A5 FR2149952 A5 FR 2149952A5 FR 7228435 A FR7228435 A FR 7228435A FR 7228435 A FR7228435 A FR 7228435A FR 2149952 A5 FR2149952 A5 FR 2149952A5
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7228435A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR2149952A5 publication Critical patent/FR2149952A5/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/62Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings
    • C07D263/64Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings linked in positions 2 and 2' by chains containing six-membered aromatic rings or ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polyesters Or Polycarbonates (AREA)
FR7228435A 1971-08-10 1972-08-07 Expired FR2149952A5 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1179971A CH561242A5 (enExample) 1971-08-10 1971-08-10

Publications (1)

Publication Number Publication Date
FR2149952A5 true FR2149952A5 (enExample) 1973-03-30

Family

ID=4376981

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7228435A Expired FR2149952A5 (enExample) 1971-08-10 1972-08-07

Country Status (9)

Country Link
CA (1) CA1018173A (enExample)
CH (1) CH561242A5 (enExample)
DD (1) DD98321A5 (enExample)
DE (1) DE2237874A1 (enExample)
FR (1) FR2149952A5 (enExample)
GB (1) GB1382459A (enExample)
IT (1) IT961914B (enExample)
NL (1) NL7210848A (enExample)
SU (1) SU611593A3 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3617451A1 (de) * 1986-05-23 1987-11-26 Hoechst Ag Sulfonat- oder sulfonamidgruppen-haltige bis-benzoxazolylnaphthaline, verfahren zu deren herstellung und deren verwendung
EP1986633B1 (en) 2006-02-10 2014-07-30 Summit Corporation Plc Treatment of duchenne muscular dystrophy
LT2170396T (lt) 2007-08-03 2017-03-10 Summit (Oxford) Limited Vaistų deriniai, skirti diušeno raumenų distrofijos gydymui

Also Published As

Publication number Publication date
SU611593A3 (ru) 1978-06-15
CA1018173A (en) 1977-09-27
GB1382459A (en) 1975-01-29
IT961914B (it) 1973-12-10
DE2237874A1 (de) 1973-02-22
NL7210848A (enExample) 1973-02-13
DD98321A5 (enExample) 1973-06-12
CH561242A5 (enExample) 1975-04-30

Similar Documents

Publication Publication Date Title
FR2149952A5 (enExample)
AU2658571A (enExample)
AU2691671A (enExample)
AU3005371A (enExample)
AU2684071A (enExample)
AU2726271A (enExample)
AU2742671A (enExample)
AU2894671A (enExample)
AU2941471A (enExample)
AU2952271A (enExample)
AU2837671A (enExample)
AU2927871A (enExample)
AU2588771A (enExample)
AU2669471A (enExample)
AU2684171A (enExample)
AU2654071A (enExample)
AU2706571A (enExample)
AU2724971A (enExample)
AU2740271A (enExample)
AU2755871A (enExample)
AU3038671A (enExample)
AU3025871A (enExample)
AU2836771A (enExample)
AU2963771A (enExample)
AU2854371A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse